XML 43 R28.htm IDEA: XBRL DOCUMENT
v3.22.0.1

REVENUES FROM CONTRACTS WITH CUSTOMERS (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2021
Revenue from Contract with Customer [Abstract] |
Schedule of Changes in Contract Assets and Contract Liabilities | The following table summarized the changes in the contract asset and liability balances for the year ended December 31, 2021:
Dollars in thousands | Total
Contract Asset |
Contract asset, January 1, 2021 | $ | 7,430 |
Transferred to trade receivable of contract asset included in beginning of the year contract asset | (7,430) |
Contract asset, net of transferred to trade receivables on contracts during the period | 11,412 |
Contract asset, December 31, 2021 | $ | 11,412 |
Contract Liability |
Contract liability, January 1, 2021 | $ | 11,961 |
Recognition of revenue included in beginning of year contract liability | (5,164) |
Contract liability, net of revenue recognized on contracts during the period | 5,175 |
Foreign currency translation | (26) |
Contract liability, December 31, 2021 | $ | 11,946 |
Schedule of Disaggregation of Revenue | The following table presents revenues disaggregated by the major sources of revenues for years-ended December 31, 2021, 2020 and 2019 (dollar amounts in thousands):
|  |  |  | Year Ended December 31, 2021 | Year Ended December 31, 2020 | Year Ended December 31, 2019
Neurosurgery |  |  |  | 802,959 |  | 716,339 |  | 767,793 |
Instruments |  |  |  | 222,273 |  | $ | 178,492 |  | $ | 228,413 |
Total Codman Specialty Surgical |  |  |  | 1,025,232 |  | 894,831 |  | 996,206 |
Wound Reconstruction and Care(2) |  |  |  | 392,463 |  | 293,038 |  | 322,739 |
Extremity Orthopedics(1) |  |  |  | — |  | 78,316 |  | 90,082 |
Private Label |  |  |  | 124,753 |  | 105,683 |  | 108,530 |
Total Tissue Technologies |  |  |  | 517,216 |  | 477,037 |  | 521,351 |
Total revenue |  |  |  | $ | 1,542,448 |  | $ | 1,371,868 |  | $ | 1,517,557 |
(1) On January 4, 2021, the Company completed its sale of its Extremity Orthopedics business. In conjunction with the sale of this business, the Company rebranded the Orthopedics and Tissue Technologies segment as Tissue Technologies in the first quarter of 2021. See Note 4. Acquisitions and Divestitures, for details. (2) See Note 4. Acquisitions and Divestitures, for details around the ACell acquisition.

X
- Definition Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130551-203045 + Details
Name: | us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration